Cryoport (CYRX) director receives restricted stock and option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cryoport, Inc. director Daniel M. Hancock reported equity awards consisting of restricted stock and stock options. He received 10,350 restricted stock rights that vest in full on June 5, 2027 and will convert into the same number of common shares when vested.
He was also granted options to buy 16,077 shares of common stock at an exercise price of $15.70 per share, expiring on June 5, 2033. One-twelfth of these options vest monthly on the 5th, starting July 5, 2026. Following the grants, he directly holds 69,052 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
HANCOCK DANIEL M
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option (Right to Buy Common Stock) | 16,077 | $0.00 | -- |
| Grant/Award | Common Stock | 10,350 | $0.00 | -- |
Holdings After Transaction:
Option (Right to Buy Common Stock) — 16,077 shares (Direct, null);
Common Stock — 69,052 shares (Direct, null)
Footnotes (1)
- Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis. 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Key Figures
Restricted stock rights granted: 10,350 rights
Options granted: 16,077 options
Option exercise price: $15.70 per share
+4 more
7 metrics
Restricted stock rights granted
10,350 rights
Grant on June 5, 2026; vest in full June 5, 2027
Options granted
16,077 options
Right to buy common stock, granted June 5, 2026
Option exercise price
$15.70 per share
Exercise price for 16,077 stock options
Option expiration date
June 5, 2033
Expiration for granted stock options
Director share holdings
69,052 shares
Common shares directly held after reported transactions
RSU vesting date
June 5, 2027
Restricted stock rights vest and convert one-for-one
Option vesting schedule
1/12 monthly
Vests on 5th of month for 12 months from July 5, 2026
Key Terms
restricted stock rights, Option (Right to Buy Common Stock), exercise price, vesting
4 terms
restricted stock rights financial
"Reflects grant of restricted stock rights that vest in full on June 5, 2027"
Restricted stock rights are ownership claims in company shares that come with limits on when or how they can be sold or transferred, often tied to time-based or performance conditions. For investors, these rights matter because they affect when insiders truly own or can monetize shares — influencing future share supply, executive incentives, and potential stock price pressure much like a savings account that only becomes withdrawable after meeting set conditions.
Option (Right to Buy Common Stock) financial
"security_title: Option (Right to Buy Common Stock) with 16,077 shares"
exercise price financial
"Options have a conversion or exercise price of 15.7000 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"1/12th of the options vest on the 5th of the month for twelve months"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did Cryoport (CYRX) director Daniel Hancock report in this Form 4?
Director Daniel M. Hancock reported receiving equity compensation awards. He was granted 10,350 restricted stock rights and 16,077 stock options, both tied to Cryoport common stock, with specific vesting schedules and no open-market buying or selling reported in this filing.
How many Cryoport (CYRX) restricted stock rights were granted to Daniel Hancock?
Daniel Hancock received 10,350 restricted stock rights. These awards vest in full on June 5, 2027 and then automatically convert into an equal number of Cryoport common shares on a one-for-one basis, reflecting time-based compensation rather than a market purchase.
What are the terms of Daniel Hancock’s Cryoport (CYRX) stock option grant?
He was granted options covering 16,077 shares of Cryoport common stock at an exercise price of $15.70 per share. The options expire on June 5, 2033, with one-twelfth of the grant vesting monthly on the 5th, beginning July 5, 2026.